Abstract
Neuroendocrine Tumors (NETs) encompass a wide variety of tumors arising from neuroendocrine cells, which produce bioactive substances. The incidence of NETs increased significantly lately, becoming one of the most common tumors of the digestive tract. Their clinical presentation is as diverse as their capacity for hormone production. Carcinoid syndrome is the most common hormonal syndrome produced by NETs and is characterized by diarrhea, flushing and cardiac valvular lesions. New research brought multiple changes in the classification of these neoplasms and a new understanding about their diagnosis and treatment, promoting a multidisciplinary approach. Somatostatin analogues, radiation, biological, and cytotoxic drugs have improved the prognosis of these patients, which entails a great challenge for healthcare providers.
| Translated title of the contribution | Update on neuroendocrine tumors |
|---|---|
| Original language | Spanish |
| Pages (from-to) | 888-898 |
| Number of pages | 11 |
| Journal | Revista Medica de Chile |
| Volume | 149 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2021 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2021 Sociedad Medica de Santiago. All rights reserved.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Biomarkers
- Tumor
- Malignant Carcinoid Syndrome
- Neuroendocrine Tumors
- Somatostatin
Fingerprint
Dive into the research topics of 'Update on neuroendocrine tumors: Un desafío transversal'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver